Form 8-K - Current report:
SEC Accession No. 0001193125-26-268518
Filing Date
2026-06-12
Accepted
2026-06-12 08:00:16
Documents
9
Period of Report
2026-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bioa-20260610.htm   iXBRL 8-K 58275
  Complete submission text file 0001193125-26-268518.txt   196126

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bioa-20260610.xsd EX-101.SCH 46302
12 EXTRACTED XBRL INSTANCE DOCUMENT bioa-20260610_htm.xml XML 5612
Mailing Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608
Business Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608 510-806-1445
BioAge Labs, Inc. (Filer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42279 | Film No.: 261084960
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)